0
0
2/20/23 at 7:45pm
Organization
Newswise
43 words
0
Comments
Brexanolone, an IV infusion comprised of a derivative of progesterone, was approved by the U.S. Food and Drug Administration for the treatment of PPD in 2019. T
You are the first to view
https://www.newswise.com/articles/researchers-uncover-mechanisms-of-brexanolone-and-the-role-of-inflammation-in-post-partum-depression
Create an account
or login to join the discussion